SPOTLIGHT -
Pharmaceutical Executive, September 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2016 issue in an interactive PDF format.
On and Off the Pharma Podium
In the spirit of the Olympics, we cite some of the feel-good and not-so-good stories making waves in the competitive world of pharma.
European Pharma and the Unified Patent Court
A look at the EU plans for a European patent, and where the UK fits in the mix.
An EU Referendum ... on Drug Pricing?
The chances are slim, but a new resolution in Europe on the subject could drum up support for a Brexit-like scenario.
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Stem Cell Therapies Still Facing Commercial Challenges
July 22, 2016
Assuring Trust in the Digital Space
Accelerating the Drive for New Antibiotics
Time for new pharma strategies to combat deadly drug-resistant infections
Pharmaceutical Executive, July 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.
“Have We Met Your Needs Today?” Patient Centricity is So Much More than a Customer Satisfaction Survey
In the healthcare industry, “patient centricity” is like comfort food – everyone knows what it is, but it can mean very different things to different people.
Transforming Commercial Models in the Pharmaceutical Industry
In this paper, we’ll explore opportunities pharma marketers have to create engaging experiences that will deliver new types of value to meet their targets’ evolving expectations.
Medication Adherence Packaging Technology
Transforming Commercial Models
Pharma Failing to Address Corruption Risks, Says Report
Policy makers "simply are not taking seriously the corrosive effect of corruption", study says.
Europe’s ‘Radical’ Regulators Drawn Further into Pricing Debate
Top officials at EMA push the boat out on drug-pricing views.
Pharmaceutical Executive, June 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2016 issue in an interactive PDF format.
Pharma Under Pressure to Curb Opioid Abuse
Policymakers seek to limit prescribing while also encouraging innovative R&D.
Pharmaceutical Executive, May 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.
Episode 2: How On-Dose Technologies Mitigate Safety Risks and Reduce Product Diversion and Counterfeiting
ACP’s Drug Cost Paper Ignores Economic Reality
The American College of Physicians chimed in on the debate surrounding prescription drug costs, offering its views for stemming the escalation. Ed Schoonveld offers a deep dive into the positions taken.
Building Regulatory Capacity: MRCT Workshop in Singapore
It’s a Revolution: Real World Data & Patient Health Outcomes
Disease Interception and the US National Cancer Moonshot
Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding
"A Gathering of Global Proportions" at DIA 2016
FDA’s Accelerated Pathways Are the New Normal
May 2016 — Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding
Information in Action: A Conversation with Barbara Lopez Kunz
How the DIA, a key industry NGO, is repositioning itself as the go-to place for the independent knowledge-driven insights that drive decisions in a business with no boundaries. One world. One table. Open seating.
R&D Model Mixes Compassion, Calculation
Altruism and self-interest are at the heart of European thinking on neglected diseases.
Drug Compounding: A Cause and Cure for High Drug Prices?
The practice’s emerging-if improbable-cost-saving potential.
